Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Centessa Pharmaceuticals Plc (CNTA)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 131,000,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Centessa Pharmaceuticals is a pharmaceutical company that develops and delivers life-altering and life-enhancing medicines to patients. Co.'s product pipeline includes: Lixivaptan, a vasopressin V2 receptor small molecule inhibitor; SerpinPC, an activated protein C inhibitor for the treatment of hemophilia A and B; Imgatuzumab, an anti-EGFR monoclonal antibody for the treatment of cutaneous squamous cell carcinoma and for the treatment of other solid tumors in the context of combination treatment with immunotherapy; and ZF874, a small molecule chemical chaperone folding corrector of the Z variant of alpha-1-antitrypsin for the treatment of alpha-1-antitrypsin deficiency.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 462,585 462,585 462,585
Total Buy Value $0 $5,865,243 $5,865,243 $5,865,243
Total People Bought 0 1 1 1
Total Buy Transactions 0 2 2 2
Total Shares Sold 187,322 394,558 1,386,169 1,499,627
Total Sell Value $2,690,807 $5,627,596 $21,991,469 $23,120,666
Total People Sold 4 5 7 8
Total Sell Transactions 10 21 55 62
End Date 2025-05-25 2025-02-21 2024-08-23 2023-08-24

   
Records found: 264
  Page 1 of 11  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Hussain Iqbal J General Counsel   •       –      –    2025-08-15 4 AS $17.23 $103,380 D/D (6,000) 105,386     -
   Hussain Iqbal J General Counsel   •       –      –    2025-08-15 4 OE $5.84 $35,040 D/D 6,000 111,386     -
   Accardi Mario Alberto President, Orexin Program   •       –      –    2025-08-01 4 D $17.17 $10,250 D/D (597) 207,566     -
   Accardi Mario Alberto President, Orexin Program   •       –      –    2025-07-29 4 AS $15.23 $126,751 D/D (8,322) 208,163     -
   Weinhoff Gregory M Chief Business Officer   •       –      –    2025-07-25 4 AS $15.56 $155,598 D/D (10,000) 122,279     -
   Weinhoff Gregory M Chief Business Officer   •       –      –    2025-07-25 4 OE $3.85 $38,500 D/D 10,000 132,279     -
   Saha Saurabh Chief Executive Officer   •       •      –    2025-07-21 4 AS $15.92 $875,600 D/D (55,000) 221,017     -
   Saha Saurabh Chief Executive Officer   •       •      –    2025-07-21 4 OE $3.85 $211,750 D/D 55,000 276,017     -
   Hussain Iqbal J General Counsel   •       –      –    2025-07-15 4 AS $14.93 $89,567 D/D (6,000) 105,386     -
   Hussain Iqbal J General Counsel   •       –      –    2025-07-15 4 OE $5.84 $35,040 D/D 6,000 111,386     -
   Weinhoff Gregory M Chief Business Officer   •       –      –    2025-06-25 4 AS $13.86 $138,642 D/D (10,000) 122,279     -
   Weinhoff Gregory M Chief Business Officer   •       –      –    2025-06-25 4 OE $3.85 $38,500 D/D 10,000 132,279     -
   Hussain Iqbal J General Counsel   •       –      –    2025-06-24 4 AS $14.02 $168,218 D/D (12,000) 105,386     -
   Hussain Iqbal J General Counsel   •       –      –    2025-06-24 4 OE $5.84 $70,080 D/D 12,000 117,386     -
   Accardi Mario Alberto President, Orexin Program   •       –      –    2025-06-24 4 AS $14.00 $210,000 D/D (15,000) 216,485     -
   Accardi Mario Alberto President, Orexin Program   •       –      –    2025-06-24 4 OE $3.85 $57,750 D/D 15,000 231,485     -
   Saha Saurabh Chief Executive Officer   •       •      –    2025-06-20 4 AS $12.63 $694,826 D/D (55,000) 221,017     -
   Saha Saurabh Chief Executive Officer   •       •      –    2025-06-20 4 OE $3.85 $211,750 D/D 55,000 276,017     -
   Accardi Mario Alberto President, Orexin ProgramOffic   •       –      –    2025-06-13 3 IO $0.00 $0 D/D 0 216,485     -
   Weinhoff Gregory M Chief Business Officer   •       –      –    2025-05-27 4 AS $12.82 $128,225 D/D (10,000) 122,279     -
   Weinhoff Gregory M Chief Business Officer   •       –      –    2025-05-27 4 OE $3.85 $38,500 D/D 10,000 132,279     -
   Saha Saurabh Chief Executive Officer   •       •      –    2025-05-20 4 AS $12.71 $699,111 D/D (55,000) 221,017     -
   Saha Saurabh Chief Executive Officer   •       •      –    2025-05-20 4 OE $3.85 $211,750 D/D 55,000 276,017     -
   Goyal Arjun Director   –       •      –    2025-05-16 4 B $12.73 $5,315,005 I/I 417,646 462,585 2.1     -
   Goyal Arjun Director   –       •      –    2025-05-15 4 B $12.24 $550,238 I/I 44,939 44,939 2.1     -
  264 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 11
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us